Koike et al. (2004) Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients. J Surg Oncol 87: 182–186
Successful treatment in gastric cancer is limited by the late detection of tumors. A recent paper by Koike and colleagues compares two PCR-based screening methods for early detection.
Preoperative blood samples were obtained from 41 gastric cancer patients and 10 healthy volunteers. Samples were subjected to two assays: CEA-specific nested RT-PCR, in which a positive result indicates that circulating tumor cells are present in the original sample; and the MSP assay, which differentiates between methylated and unmethylated promoter regions of the p16, E-cadherin and RAR[beta] genes. Hypermethylation is a marker of downregulation or silencing of tumor suppressor genes, and hence indicates that tumor DNA fragments are present.
The CEA-specific RT-PCR assay gave a positive result in 10 (24%) patients and the detection rate was higher in stage III or IV disease than in stages I or II (P < 0.01). The MSP assay detected aberrant methylation of p16 in 9 (22%) patients, E-cadherin in 9 (22%) patients and RAR[beta] in 6 (15%) patients. Overall, 18 (44%) patients showed aberrant methylation of the promoter region of at least one of the genes tested, and a positive result correlated with venous invasion (P < 0.05).
While the overall detection rate of the MSP assay was higher than that for CEA-specific RT-PCR, Koike et al. suggest that both assays will be useful for identifying patients requiring more intensive screening and treatment.
Rights and permissions
About this article
Cite this article
Early detection in gastric cancer. Nat Rev Gastroenterol Hepatol 1, 9 (2004). https://doi.org/10.1038/ncpgasthep0023
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0023